Umesh Yogarajah - In Practice

Real Clinics. Real Patients. Real Oncology.

Home

/ Authors /

Umesh Yogarajah

Umesh Yogarajah

,

PharmD

Clinical Specialist, Malignant Hematology

Roswell Park Comprehensive Cancer Center, Buffalo, NY

From this Author

Patient Populations

Managing and Mitigating Discontinuation Syndrome With Ruxolitinib and Other Novel JAK Inhibitors for Myelofibrosis

Managing and Mitigating Discontinuation Syndrome With Ruxolitinib and Other Novel JAK Inhibitors for Myelofibrosis

Justin Arnall, PharmD, BCOP; Joseph Elmes, PharmD, BCOP, et al.

August 13, 2026

Oncology is evolving. Stay current.

Weekly breakthroughs, expert insights, and clinical updates —delivered to your inbox.